Search

Your search keyword '"Baratelli, Felicita"' showing total 26 results

Search Constraints

Start Over You searched for: Author "Baratelli, Felicita" Remove constraint Author: "Baratelli, Felicita" Language english Remove constraint Language: english
26 results on '"Baratelli, Felicita"'

Search Results

1. IL-27 inhibits epithelial-mesenchymal transition and angiogenic factor production in a STAT1-dominant pathway in human non-small cell lung cancer

7. Pre-clinical characterization of GMP grade CCL21-gene modified dendritic cells for application in a phase I trial in Non-Small Cell Lung Cancer

8. Overexpression of CCL-21/Secondary Lymphoid Tissue Chemokine in Human Dendritic Cells Augments Chemotactic Activities for Lymphocytes and Antigen Presenting Cells

9. CCL21 Chemokine Therapy for Lung Cancer

10. MA09.07 Phase I Trial of in situ Vaccination with CCL21 Gene-Modified DC Induces Specific Systemic Immune Response and Tumor Infiltrating CD8+ T Cells

11. Overexpression of CCL-21/Secondary Lymphoid Tissue Chemokine in Human Dendritic Cells Augments Chemotactic Activities for Lymphocytes and Antigen Presenting Cells

12. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one: National Harbor, MD, USA. 9-13 November 2016

13. Novel CCL21-Vault Nanocapsule Intratumoral Delivery Inhibits Lung Cancer Growth.

14. Pre-clinical characterization of GMP grade CCL21-gene modified dendritic cells for application in a phase I trial in Non-Small Cell Lung Cancer.

15. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

16. IL-20, an anti-angiogenic cytokine that inhibits COX-2 expression

17. Phase I Trial of Intratumoral Injection of CCL21 Gene-Modified Dendritic Cells in Lung Cancer Elicits Tumor-Specific Immune Responses and CD8 + T-cell Infiltration.

18. CCL21 Chemokine Therapy for Lung Cancer.

19. PGE(2) contributes to TGF-beta induced T regulatory cell function in human non-small cell lung cancer.

20. Prostaglandin E2 induces FOXP3 gene expression and T regulatory cell function in human CD4+ T cells.

21. PGE2 confers survivin-dependent apoptosis resistance in human monocyte-derived dendritic cells.

22. Tumor cyclooxygenase-2/prostaglandin E2-dependent promotion of FOXP3 expression and CD4+ CD25+ T regulatory cell activities in lung cancer.

23. Prostaglandin E2-dependent enhancement of tissue inhibitors of metalloproteinases-1 production limits dendritic cell migration through extracellular matrix.

24. Modulation of pulmonary leukotriene B4 production by cyclooxygenase-2 inhibitors and lipopolysaccharide.

25. Celecoxib modulates the capacity for prostaglandin E2 and interleukin-10 production in alveolar macrophages from active smokers.

26. Tumor cyclooxygenase 2-dependent suppression of dendritic cell function.

Catalog

Books, media, physical & digital resources